| AGEs | Advanced glycosylation end products |
| ATP | Adenosine triphosphate |
| B1 | Vitamin B1 |
| BAVA | Attenuated brachial artery vasoactivity |
| BBB | Blood–brain barrier |
| BCAAs | Branched-chain amino acids |
| CALR | Calreticulin |
| CF | Coronary flow |
| CI | Confidence interval |
| CPT1/2 | Carnitine palmitoyltransferase 1 and 2 |
| CVD | Cardiovascular disease |
| DLVP | Diastolic left ventricular development |
| DM | Diabetes mellitus |
| DOX | Doxorubicin |
| dp/dt max | Maximum rate of left ventricular development |
| dp/dt min | Minimum rate of left ventricular development |
| EAR | Estimated average requirement |
| EDV | Endothelium-dependent vasodilation |
| EF | Ejection fraction |
| eNOS | Endothelial nitric oxide synthase |
| ETK | Erythrocyte transketolase |
| ETKA | Erythrocyte transketolase activation assay |
| FAD | Flavin adenine dinucleotide |
| FADH2 | Flavin adenine dinucleotide |
| FBS | Fasting blood sugar |
| FDA | Food and Drug Administration |
| FS | Fractional shortening |
| GDM | Gestational diabetes mellitus |
| GSH | Glutathione |
| HACL1 | 2-hydroxyacyl-CoA lyase 1 |
| HbA1c | Glycated hemoglobin |
| HDLs | High-density lipoproteins |
| HF | Heart failure |
| HFpEF | Heart failure with preserved ejection fraction |
| HO• | Hydroxyl radicals |
| HO-1 | Heme oxygenase 1 |
| HOO• | Hydroperoxyl radicals |
| HPLC | High-performance liquid chromatography |
| HPLC–MS/MS | High-performance liquid chromatography–tandem mass spectrometry |
| HR | Heart rate |
| hs-CRP | High-sensitivity C-reactive protein |
| hTHTR-1 | Human thiamine transporter-1 |
| hTHTR-2 | Human thiamine transporter-2 |
| hTPPT | Human thiamine pyrophosphate transporter |
| HUVECs | Human umbilical vein endothelial cells |
| IC50 | Half-maximal inhibitory concentration |
| ICAM-1 | Intercellular adhesion molecule 1 |
| IGT | Impaired glucose tolerance |
| iNOS | Nitric oxide inducible synthase |
| JAK2 | Janus kinase 2 |
| KGDHC | Alpha-ketoglutarate dehydrogenase complex |
| LDL | Low-density lipoprotein |
| LDLc | Low-density lipoprotein cholesterol |
| L-NAME | NG-nitro-L-arginine-methyl-ester |
| LV | Left ventricle |
| LVEF | Left ventricular ejection fraction |
| LVIDd | Left ventricle internal dimension at end-diastole |
| LVIDs | Left ventricle internal dimension at end-systole |
| LVPWd | Left ventricle internal dimension at end-diastole |
| LVPWs | Left ventricular posterior wall thickness at end-systole |
| MALDI-MS | Matrix-assisted laser desorption/ionization mass spectrometry |
| MDA | Malondialdehyde |
| MI | Myocardial infarction |
| MTPP-1 | Mitochondrial thiamin pyrophosphate transporter 1 |
| NADH | Nicotinamide adenine dinucleotide |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NF-k B | Nuclear factor kappa B |
| NF-KB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NIDDM | Non-insulin-dependent diabetes mellitus |
| NO | Nitric oxide |
| NOS | Nitric oxide synthase |
| OCT1 | Organic cation transporter 1 |
| OCT2/3 | Organic cation transporter 2 and 3 |
| OR | Odds ratio |
| P2Y6 | Pyrimidinergic receptor P2Y6 |
| PAD | Peripheral arterial disease |
| PARP | Poly (ADP-ribose) polymerase |
| PDH | Pyruvate dehydrogenase |
| PDK | Pyruvate dehydrogenase kinase |
| PPP | Pentose phosphate pathway |
| RBCs | Red blood cells |
| RBS | Random blood sugar |
| RDA | Recommended daily allowance |
| RF | Renal failure |
| ROS | Reactive oxygen species |
| SAM | Severe acute malnutrition |
| SLC19A1 | Solute carrier family 19 member 1 |
| SLC19A2 | Solute carrier family 19 member 2 |
| SLC19A3 | Solute carrier family 19 member 3 |
| SLC22A1 | Solute carrier family 22 member 1 |
| SLC25A19 | Solute carrier family 25 member 19 |
| SLC35F3 | Solute carrier family 35 member F3 |
| SLC44A4 | Solute carrier family 44 member 4 |
| SLVP | Systolic left ventricular development |
| SOD | Superoxide dismutase |
| Sp1 | Transcription factor specificity protein-1 |
| STIM1 | Stromal Interaction Molecule 1 |
| T1D | Type 1 diabetes |
| T2D | Type 2 diabetes |
| T2DM | Type 2 diabetes mellitus |
| TCA | Tricarboxylic citric acid |
| TD | Thiamine deficiency |
| TDDs | Thiamine deficiency disorders |
| ThDP | Thiamine diphosphate |
| THIA | Thiamine |
| THTR1 | Thiamine transporter-1 |
| THTR2 | Thiamine transporter-2 |
| TK | Transketolase enzyme |
| TMP | Thiamine monophosphate |
| TNF-α | Tumor necrosis factor-alpha |
| TPK1 | Thiamine pyrophosphokinase 1 |
| TPP | Thiamine pyrophosphate |
| TPPE | Effect of thiamine pyrophosphate |
| TPPT-1 | Thiamine pyrophosphate transporter 1 |
| TRMA | Thiamine-responsive megaloblastic anemia |
| TSH | Thyroid-stimulating hormone |
| US | United States |
| UTP | Uridine 5′-triphosphate |
| Vo2 | Oxygen consumption |